At what hemoglobin, ferritin, or symptom thresholds should further treatment be initiated for anemia during pregnancy?

Treatment Thresholds for Anemia in Pregnancy

Further treatment for anemia in pregnancy should be initiated when hemoglobin falls below 11 g/dL in the first and third trimesters or below 10.5 g/dL in the second trimester, combined with ferritin <30 μg/L to confirm iron deficiency. 1, 2, 3

Diagnostic Thresholds

Hemoglobin Cutoffs by Trimester

• First trimester: <11 g/dL
• Second trimester: <10.5 g/dL
• Third trimester: <11 g/dL
• Postpartum: <10 g/dL

These thresholds represent the most current international consensus 1 and align with ACOG recommendations 3.

Ferritin Threshold for Iron Deficiency

Ferritin <30 μg/L defines iron deficiency in pregnancy 4, 2. This is critical because iron deficiency causes symptoms and fetal neurodevelopmental effects even before anemia develops 2.

Severity Classification

Once anemia is diagnosed, classify severity to guide treatment intensity:

• Mild: Hemoglobin 10-10.4 g/dL
• Moderate: Hemoglobin 9-9.9 g/dL (or 7.0-9.9 g/dL per some definitions)
• Severe: Hemoglobin <9 g/dL (or <7 g/dL for very severe)

4, 3

Screening Schedule

Screen all pregnant women at:

1. Booking/first prenatal visit with complete blood count and ferritin
2. 24-28 weeks gestation (repeat screening)
3. 36 weeks if clinically indicated or previously unscreened

1, 2, 3

This approach catches both early pregnancy anemia (associated with worse outcomes) and later-developing deficiency 5.

Treatment Algorithm Based on Severity

Mild to Moderate Anemia (Hb 9-10.4 g/dL)

First-line: Oral iron supplementation 4, 2, 3

• Alternate-day dosing is as effective as daily dosing with fewer side effects 2, 3
• If mild anemia with normal/mildly low MCV, oral iron trial is both diagnostic and therapeutic 3

When to Escalate to Intravenous Iron

Offer IV iron for:

• Intolerance to oral iron
• Failure to respond to oral iron
• Third trimester presentation (insufficient time for oral iron to work)
• Severe anemia (Hb <9 g/dL or <8 g/dL depending on source)
• Women at high risk for major bleeding (e.g., placenta accreta)
• Women who refuse blood transfusion

4, 2, 3, 6

Ferric carboxymaltose has proven efficacy and safety in pregnancy 4, and contemporary IV iron formulations have rare allergic reactions 3.

Severe Anemia Requiring Further Investigation

Obtain additional workup when:

• Very low MCV (suggests thalassemia or other hemoglobinopathy)
• Macrocytic anemia (suggests B12/folate deficiency)
• Moderate to severe anemia (Hb <10 g/dL)
• No response to appropriate iron therapy

3

Blood Transfusion

Reserved for very severe anemia with cardiovascular instability 4. Maternal anemia increases transfusion likelihood at delivery 3.

Critical Pitfalls

Don't wait for anemia to develop. Iron deficiency without anemia causes maternal symptoms (fatigue, mood changes, poor concentration) and impairs fetal neurodevelopment with lasting effects 2. Treating ferritin <30 μg/L even with normal hemoglobin prevents progression and complications.

Don't assume third-trimester anemia is benign. While older data suggested late pregnancy anemia may be less harmful 5, current evidence emphasizes treating it aggressively due to PPH risk and insufficient time for oral iron correction 1, 6.

Don't overlook the 28-week screening. Many women develop iron deficiency in the second half of pregnancy due to increased fetal demands 2.

Evidence Quality Note

The USPSTF found insufficient evidence in 2015 to recommend for or against screening 5, but this reflects limitations in demonstrating outcome improvements in well-nourished U.S. populations, not a recommendation against screening. More recent international guidelines (2025-2026) strongly support universal screening and treatment based on the high global burden of maternal anemia contributing to >115,000 maternal deaths annually 1 and the established harms of untreated iron deficiency 2.